dc.contributor.author |
Sanchez, Flor |
|
dc.contributor.author |
Le, A.H. |
|
dc.contributor.author |
Ho, V.N.A. |
|
dc.contributor.author |
Romero Loyola, Sergio Jean Markos |
|
dc.contributor.author |
Van Ranst, H. |
|
dc.contributor.author |
De Vos, M. |
|
dc.contributor.author |
Gilchrist, R.B. |
|
dc.contributor.author |
Ho, T.M. |
|
dc.contributor.author |
Vuong, L.N. |
|
dc.contributor.author |
Smitz, J. |
|
dc.date.accessioned |
2019-12-06T21:04:52Z |
|
dc.date.available |
2019-12-06T21:04:52Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/7654 |
|
dc.description.abstract |
Purpose: To investigate the effectiveness of a biphasic IVM culture strategy at improving IVM outcomes in oocytes from small follicles (< 6 mm) compared with routine Standard IVM in patients with polycystic ovaries. Methods: This prospective pilot study was performed in 40 women with polycystic ovaries whose oocytes were randomized to two IVM culture methods. Patients received a total stimulation dose of 450 IU rFSH. Cumulus-oocyte complexes (COCs) from follicles < 6 mm and ≥ 6 mm were retrieved and cultured separately in either a prematuration medium with c-type natriuretic peptide followed by IVM (CAPA-IVM), or STD-IVM. Primary outcomes were maturation rate, embryo quality, and the number of vitrified day 3 embryos per patient. Results: Use of the CAPA-IVM system led to a significant improvement in oocyte maturation (p < 0.05), to a doubling in percentage of good and top-quality day 3 embryos per COC, and to an increased number of vitrified day 3 embryos (p < 0.001), compared to STD IVM. Oocytes from follicles < 6 mm benefited most from CAPA-IVM, showing a significant increase in the amount of good and top-quality embryos compared to STD IVM. CAPA-IVM yielded significantly (p < 0.0001) less GV-arrested oocytes and larger oocyte diameters (p < 0.05) than STD IVM. Conclusions: CAPA-IVM brings significant improvements in maturation and embryological outcomes, most notably to oocytes from small antral follicles (< 6 mm), which can be easily retrieved from patients with a minimal ovarian stimulation. The study demonstrates the robustness and transferability of the CAPA-IVM method across laboratories and populations. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer |
|
dc.relation.ispartofseries |
Journal of Assisted Reproduction and Genetics |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
human |
en_US |
dc.subject |
embryo |
en_US |
dc.subject |
IVM |
en_US |
dc.subject |
priority journal |
en_US |
dc.subject |
Article |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
female |
en_US |
dc.subject |
human cell |
en_US |
dc.subject |
adult |
en_US |
dc.subject |
clinical outcome |
en_US |
dc.subject |
prospective study |
en_US |
dc.subject |
clinical article |
en_US |
dc.subject |
antral follicle |
en_US |
dc.subject |
C-type natriuretic peptide |
en_US |
dc.subject |
cell count |
en_US |
dc.subject |
cell size |
en_US |
dc.subject |
Embryo |
en_US |
dc.subject |
in vitro oocyte maturation |
en_US |
dc.subject |
IVF |
en_US |
dc.subject |
natriuretic peptide type C |
en_US |
dc.subject |
oocyte development |
en_US |
dc.subject |
Oocyte prematuration |
en_US |
dc.subject |
ovary polycystic disease |
en_US |
dc.subject |
recombinant follitropin |
en_US |
dc.subject |
vitrification |
en_US |
dc.title |
Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1007/s10815-019-01551-5 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.02 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.02 |
|
dc.relation.issn |
1573-7330 |
|